Navigation Links
Illuminated Trial Lens Set

ProductsIlluminated Trial Lens Set
Company Khosla Medical & Surgical, Inc.
Item Illuminated Trial Lens Set
Features Lenses are of plano form, back vertex power, 20 mm aperture spun into aluminum mounts Of 38 mm diameter. Plus and minus mounts are anodized in different colors. Handles are provided on spheres, but not on cylinders and prisms. The case is made of seasoned wood. The lens tray rises on lifting the lid and the set is automatically Illuminated.
Description Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy.
Info Khosla Medical & Surgical, Inc.
Customer Service: (408) 996 0205
Web site: http://www.khosla-med.com/

Related medicine products :

1. Illuminated Phoroptor
2. Non-Illuminated Trial Lens Set
3. Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted
4. Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted
5. Illuminated Stand Magnifier
6. Illuminated PHOROPTOR Refracting Instrument
7. Illuminated PHOROPTOR Refracting Instrument - Minus Cylinder White
8. Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder Black
9. Illuminated PHOROPTOR Refracting Instrument - Plus Cylinder White
10. Burton 7500-I Illuminated Refractor
11. Illuminated Laser Probe, Wide Field, Fully Reusable, Autoclavable
Breaking Medicine News(10 mins):Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4Health News:New study finds low rate of injuries at overnight summer camp 2Health News:DNA Test May Detect Immune Disorder in Infants 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21
Breaking Medicine Technology:Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 1Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 2Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 4Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 1Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 2Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 3Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 4Brookstone Pharmaceuticals LLC becomes Acella Pharmaceuticals LLC 6284 1